SUNRRISE has a feasibility phase that aims to recruit 70 patients over 6-months from at least 5 sites and it is set to begin November 2018. We have now identified the sites that will be participating in the feasibility phase.
We are still accepting sites for the full phase. If you are interested in participating, please complete the Site Feasibility Assessment and Registration Form and return it to the SUNRRISE Trial Office. The study setup of full phase sites will take place whilst the feasibility phase is ongoing to allow the them to open as soon as possible upon completion of the feasibility phase.
If you have any queries or would like to discuss participation as a site in the trial, please contact the SUNRRISE Trial Office.